An official website of the United States government
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

The most recent appropriations for the Department of War expired at 11:59 p.m. EST on September 30, 2025. Military personnel will continue in a normal duty status without pay until such time as a continuing resolution or appropriations are passed by Congress and signed into law. Civilian personnel not engaged in excepted activities will be placed in a non-work, non-pay status.
If you have a scheduled appointment or other business at the MTF, please verify with your provider or applicable office within the MTF to ensure there are no changes in schedule. To learn how the lapse in appropriations affects your TRICARE benefit, visit 
tricare.mil/shutdown.
News | March 4, 2021

New Infusion Clinic offers treatment option for some COVID patients

By Lori Newman

DVIDS - News - New Infusion Clinic offers treatment option for some COVID patients

Brooke Army Medical Center opened a new Infusion Clinic to help high risk COVID-positive patients whose symptoms are mild to moderate.

The treatment involves IV infusion of investigational antibody medications that are not Food and Drug Administration approved, but are authorized under an FDA emergency use authorization.

“The goal of this treatment is to halt the progression of COVID, and to hopefully prevent inpatient admission,” said Air Force Maj. (Dr.) Joseph Yabes Jr., Infectious Disease Clinic officer in charge. “Overall people have had good responses to this therapy.”

Full Story

News | March 4, 2021

New Infusion Clinic offers treatment option for some COVID patients

By Lori Newman

DVIDS - News - New Infusion Clinic offers treatment option for some COVID patients

Brooke Army Medical Center opened a new Infusion Clinic to help high risk COVID-positive patients whose symptoms are mild to moderate.

The treatment involves IV infusion of investigational antibody medications that are not Food and Drug Administration approved, but are authorized under an FDA emergency use authorization.

“The goal of this treatment is to halt the progression of COVID, and to hopefully prevent inpatient admission,” said Air Force Maj. (Dr.) Joseph Yabes Jr., Infectious Disease Clinic officer in charge. “Overall people have had good responses to this therapy.”

Full Story

Don’t forget to keep your family’s information up to date in DEERS!